For other countries, any question or an interest in distributing OncoDEEP in your country please contact us at email@example.com
OncoDNA, the Cancer Theranostic Company, announced today that it has entered into a distribution agreement with Providens, a company that provides a wide range of high-quality services to bio- and pharmaceutical companies for the region of South East Europe. Providens will market and distribute OncoDNA’s solutions to oncologists and their patients in Croatia, Bosnia-Herzegovina, Slovenia, Serbia, Montenegro and Macedonia.
Oncologists from the region will have access to a state-of-the-art molecular profiling program that combines liquid and solid biopsies analyses aspiring to improve the lives of patients with metastatic cancer. Patients will benefit from a personalized medicine based on the most comprehensive tumour profiling solution.
“This partnership is an important step towards granting patients across South East Europe access to our smart cancer precision medicine solutions. We are very pleased to enter into this agreement with Providens to allow cancer patients to benefit from the best care in oncology. This underlines the importance of improving cancer patient management and unlocks the promises of personalized treatment schemes.”, says Fiona Demol, International Business Development Manager at OncoDNA.
“This agreement will enable our companies to fully utilize their experience, accumulated knowledge and far - reaching potential of OncoDNA' s advanced solutions in a highly demanding treatment decisions of malignant diseases. We are pleased to work with OncoDNA on this extraordinary tool to oncologists and their commitment to patients” says Biserka Ciganović, General manager at Providens.
If you are a medical doctor from the region (Slovenia, Croatia, Bosnia-Herzegovina, Serbia, Montenegro and Macedonia) and you would like to discuss about a collaboration, please contact OncoDNA’s local coordinator: Mrs. Sara Ciganović firstname.lastname@example.org.
Based in Belgium, OncoDNA is a leader in the area of personalised molecular analysis for cancer patients. OncoKDM, a software for data interpretation and reporting, is the latest addition to the three solutions that OncoDNA has been offering on the market, namely OncoSTRAT&GO, OncoDEEP and OncoTRACE.
Every interaction and all of the analyses results are shared with oncologists online via the OncoSHARE platform which currently represents the largest online community in the area of cancer care, with more than 12,000 people, more than 250 hospitals and 60 countries around the world. Every medical intervention helps doctors to select a treatment and/or enhance how patients' tumours are monitored.
In 2015, OncoDNA received the award for "Most Promising Company of the Year" from Ernst&Young, as well as the prize for "Most Disruptive Innovator" from Deloitte. In 2016, the AWEX [Walloon Export and Foreign Investment Agency] awarded them the prize "Tremplin à l’Exportation – Grande Exportation" ["Springboard for Exportation - Large-Scale Exports"]. More information at www.oncodna.com
Providens is an independent, privately owned company that provides a wide range of high-quality services to bio- and pharmaceutical companies for the region of South East Europe.
Providens was founded in 1997 as a Partner of several pharmaceutical companies. In that short period of time, we are proud to have become recognized by our partners
The network of our offices, based on excellence and unique know-how to ensure a focused and modern marketing approach, has resulted in Providens being one of the fastest growing companies in the Region.More information at www.providens.org
OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology.